發(fā)展歷程
| 2024 | SM-1聯(lián)合替莫唑胺治療復(fù)發(fā)高級別腦膠質(zhì)瘤II期臨床研究啟動； SM-1聯(lián)合替莫唑胺治療初治高級別腦膠質(zhì)瘤II期臨床研究獲得臨床試驗許可。 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2023 | “真興醫(yī)藥”被評選為第五屆粵港灣大灣區(qū)生物科技創(chuàng)新企業(yè)50強(qiáng)； SM-1項目II期臨床試驗在山東大學(xué)第二醫(yī)院正式啟動； SM-1聯(lián)合替莫唑胺治療高級別腦膠質(zhì)瘤I期研究數(shù)據(jù)在＂第八屆中國醫(yī)藥創(chuàng)新與投資大會＂臨床數(shù)據(jù)首發(fā)專場中披露。 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2022 | SM-1開展Ⅱ期臨床研究； SM-1聯(lián)合放療治療頭頸部腫瘤I期臨床研究獲批。 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2021 | SM-1聯(lián)合替莫唑胺治療高級別腦膠質(zhì)瘤I期臨床研究獲批；ZXS-001項目啟動預(yù)實驗研究； ZXS-001項目啟動預(yù)實驗研究。 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2020 | SM-1項目獲得倫理批件，正式啟動臨床研究； 真興醫(yī)藥完成首輪融資； ZXBT-1158項目獲得臨床試驗許可。 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2019 | SM-1項目獲得臨床試驗許可； ZXBT-1158項目完成臨床前研究。 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2018 | SM-1項目提交臨床試驗申請； ZXBT-1158項目發(fā)明專利授權(quán)； | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2016 | ZXBT-1158項目立項 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2014 | 深圳市真興醫(yī)藥技術(shù)有限公司成立； SM-1項目獲深圳市科創(chuàng)委“協(xié)同創(chuàng)新計劃”立項； SM-1項目啟動臨床前研究； | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2013 | 深圳市真興貝特醫(yī)藥技術(shù)有限公司成立 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2012 | SM-1項目獲國家“十二五”“重大新藥創(chuàng)制”科技重大專項課題立項 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2010 | SM-1首項發(fā)明專利授權(quán) | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2009 | 篩選出新型靶向小分子化合物SM-1 | ||||||||
| 一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一一 | |||||||||
| 2007 | 成立深圳市湘雅生物醫(yī)藥研究院，從事新型靶向小分子抗腫瘤藥物研發(fā)，致力于開發(fā)擁有自主知識產(chǎn)權(quán)的原創(chuàng)藥物。 | ||||||||
微信公眾號
掃描二維碼分享到微信
